Trial Profile
A randomized, double-blind, multi-center study comparing the effects of carvedilol phosphate modified release formulation (Coreg-MR) with metoprolol succinate (Toprol XL) on the lipid profile in normolipidemic, or mildly dyslipidemic hypertensive patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jul 2023
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary) ; Metoprolol
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 02 Feb 2010 Actual number of patients (568) and actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2007 Status changed from recruiting to in progress.